These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Clinical pharmacology of the neuromuscular blocking agents. Larijani GE; Gratz I; Silverberg M; Jacobi AG DICP; 1991 Jan; 25(1):54-64. PubMed ID: 1672571 [TBL] [Abstract][Full Text] [Related]
10. Rapacuronium (Org 9487): do we have a replacement for succinylcholine? Goulden MR; Hunter JM Br J Anaesth; 1999 Apr; 82(4):489-92. PubMed ID: 10472209 [No Abstract] [Full Text] [Related]
11. Newer neuromuscular blocking agents: how do they compare with established agents? Sparr HJ; Beaufort TM; Fuchs-Buder T Drugs; 2001; 61(7):919-42. PubMed ID: 11434449 [TBL] [Abstract][Full Text] [Related]
12. The pharmacoeconomics of neuromuscular blocking drugs. Chiu JW; White PF Anesth Analg; 2000 May; 90(5 Suppl):S19-S23. PubMed ID: 10809514 [No Abstract] [Full Text] [Related]
13. [Newly developed muscle relaxants]. Fukushima K Masui; 1997 Nov; 46 Suppl():S200-4. PubMed ID: 9508579 [No Abstract] [Full Text] [Related]
14. A comparative study of pharmacokinetics and pharmacodynamics of vecuronium in children and adults. Xue F; Liu Q; Zou Q; Luo L Chin Med J (Engl); 1998 Jan; 111(1):84-5. PubMed ID: 10322663 [No Abstract] [Full Text] [Related]
15. Rapacuronium: first experience in clinical practice. Bartkowski RR; Witkowski TA Eur J Anaesthesiol Suppl; 2001; 23():90-3. PubMed ID: 11766254 [TBL] [Abstract][Full Text] [Related]
16. Clinical pharmacology of ORG 7617, a short-acting non-depolarizing neuromuscular blocking agent. van den Broek L; Wierda JM; Proost JH; Hommes FD; Agoston S Eur J Clin Pharmacol; 1994; 46(3):225-9. PubMed ID: 7915236 [TBL] [Abstract][Full Text] [Related]
17. Precurarization and priming: a theoretical analysis of safety and timing. Kopman AF; Khan NA; Neuman GG Anesth Analg; 2001 Nov; 93(5):1253-6. PubMed ID: 11682407 [TBL] [Abstract][Full Text] [Related]
18. Interactions between mivacurium, rocuronium, and vecuronium during general anesthesia. Kim DW; Joshi GP; White PF; Johnson ER Anesth Analg; 1996 Oct; 83(4):818-22. PubMed ID: 8831328 [TBL] [Abstract][Full Text] [Related]
19. Effects on laryngeal muscles and intubating conditions with new generation muscle relaxants. Meistelman C Acta Anaesthesiol Belg; 1997; 48(1):11-4. PubMed ID: 9099303 [No Abstract] [Full Text] [Related]
20. Impact of preoperative anticonvulsant therapy on vecuronium-induced neuromuscular block under sevoflurane anesthesia: a retrospective clinical study. Kawamura G; Kitamura T; Ohno N; Tashiro Y; Asahara M; Sato K; Yamada Y Masui; 2013 Aug; 62(8):935-8. PubMed ID: 23984567 [No Abstract] [Full Text] [Related] [Next] [New Search]